The global cancer screening market is anticipated to grow at a CAGR of 10.0% during the forecast period. The rising prevalence of cancer is the major factor behind the rising demand for cancer screening globally. The awareness programs initiated by governments across the globe for early diagnosis and treatment of cancer are also supporting the growth of the market. For instance, in November 2018, the European Commission announced the availability of the European Commission Initiative on Breast Cancer (ECIBC) recommendations about breast cancer imaging and diagnosis. The ECIBC develops the European Breast Guidelines, evidence-based references to provide women and healthcare providers with bright, objective, and individualistic guidance on breast cancer screening and diagnosis.
Get Free Sample link @ https://www.omrglobal.com/request-sample/cancer-screening-market
However, the high cost associated with the cancer screening types may hamper the growth of the market in developing countries due to the lower disposable income. This report will further analyze all the primary and secondary factors that are directly or indirectly influencing the growth of the cancer screening market during the forecast period.
Diagnosis and treatment of several patients with different disorders were postponed during the COVID-19 crisis as hospital beds were reserved for COVID-19 patients. Due to this reason the market players had reported a significant decline during the COVID-19 pandemic. However, as the situation got normalized the market had bounced back to its pre-COVID-19 pandemic level.
Segmental Outlook
The global cancer screening market is segmented based on the screening type and application. Based on the screening type, the market is segmented into diagnostic imaging tests, biopsy & cytology tests, tumor biomarkers, and others. Among these screening types, diagnostic imaging tests hold the major share in the market, as it is an initial level for the test performed on any patients having cancer symptoms. Moreover, it is a more economical type of screening test as compared to other screening types.
Full report of Cancer Screening Market available @ https://www.omrglobal.com/industry-reports/cancer-screening-market
Based on the application, the market is sub-segmented into breast cancer, lung cancer, cervical cancer, kidney cancer, liver cancer, pancreatic cancer, ovarian cancer, and others. Breast cancer holds a considerable share in the market as it is the most frequent cancer among women across the globe. According to the Breast Cancer Foundation Organization, in 2020, there were over 684,996 mortality from breast cancer. Survival rates of breast cancer are high if the cancer is diagnosed at an early stage, however 80% of the breast cancers are diagnosed at an advanced stage. Thus, various foundations are supporting breast cancer-specific initiatives including The Breast Cancer Research Foundation. In October 2020, The Breast Cancer Foundation announced that it is funding $40 million for breast cancer research from 2020-to 2021. Additionally, BCRF’s 40% grants are for Metastatic breast cancer which funded 88 projects in 2020. These factors are driving the growth of this segment in the market.
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/cancer-screening-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.